David Kimball



David Kimball, PhD, is currently Interim Senior Vice President of Research and Economic Development at Rutgers University, in the Office of Research and Economic Development.  He also heads the Rutgers Biomedical Research Innovation Cores (RUBRIC) group and is a Research Professor in the Ernest Mario School of Pharmacy.

David obtained his PhD in Organic Chemistry/Chemical Biology from the State University of New York at Stony Brook, and spent the first 19 years of his career at Bristol-Myers Squibb Pharmaceutical Research Institute, leading drug discovery and development efforts in cardiovascular medicine and oncology. In 2001, he moved to Lexicon Pharmaceuticals in Princeton, NJ as Vice President of Chemistry and directed discovery and development chemistry efforts for Lexicon’s entire small molecule clinical pipeline. David also served as Senior Vice President of Nonclinical Research at Pharmacopeia, Inc., and Chief Scientific Officer of Hydra Biosciences, in Cambridge, MA. He has played a leading role in the discovery and development of a dozen clinical compounds.

David joined Rutgers University in 2011 and was involved in the merger of Rutgers with the University of Medicine and Dentistry of New Jersey.  After the merger, he took on responsibility for staffing and reorganizing technology commercialization and outreach functions across the newly expanded university.